Voyager Therapeutics (VYGR) Shares Outstanding (2014 - 2026)

Voyager Therapeutics has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $60.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 9.24% year-over-year to $60.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.3 million (up 9.24% YoY) and the FY2025 annual result came in at $59.0 million, up 7.89% from the prior year.
• Shares Outstanding (Entity) grew to $60.3 million in Q1 2026 per VYGR's latest filing, from $59.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $60.3 million in Q1 2026 and troughed at $38.2 million in Q1 2022.
• A 5-year average of $49.0 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) climbed 25.05% in 2024, then rose 1.64% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $38.6 million in 2022, then advanced by 14.05% to $44.0 million in 2023, then increased by 24.28% to $54.7 million in 2024, then climbed by 7.89% to $59.0 million in 2025, then advanced by 2.14% to $60.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $60.3 million, $59.0 million, and $55.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.